{
"@context": "https://schema.org",
"@type": "Article",
"headline": "CMS Innovation Center Announces Sickle Cell Disease Focus under Cell and Gene Therapy Access Model",
"url": "https://www.lexblog.com/2024/02/06/cms-innovation-center-announces-sickle-cell-disease-focus-under-cell-and-gene-therapy-access-model-2/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-9PRM0STN",
"url": "https://www.lexblog.com/lib/9PRM0STN/"
},
"datePublished": "2024-02-06T19:55:10-05:00",
"dateModified": "2026-02-13T13:19:31-05:00",
"author": {
"@type": "Person",
"name": "Troy A. Barsky, Allison Kwon"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Crowell & Moring LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Trends in Transformation",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.openlegalblogarchive.org/2024/02/06/cms-innovation-center-announces-sickle-cell-disease-focus-under-cell-and-gene-therapy-access-model/",
"sourceStability": "may-move"
}